Poseida Therapeutics Stock Price on May 23, 2024
| PSTX Stock | USD 9.33 0.05 0.53% |
Below is the normalized historical share price chart for Poseida Therapeutics extending back to July 10, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Poseida Therapeutics stands at 9.33, as last reported on the 28th of November, with the highest price reaching 9.42 and the lowest price hitting 9.33 during the day.
If you're considering investing in Poseida Stock, it is important to understand the factors that can impact its price. Poseida Therapeutics is dangerous given 3 months investment horizon. Poseida Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.66% are justified by taking the suggested risk. Use Poseida Therapeutics Semi Deviation of 3.07, coefficient of variation of 794.08, and Risk Adjusted Performance of 0.1062 to evaluate company specific risk that cannot be diversified away.
At this time, Poseida Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 10.9 K in 2024, whereas Common Stock is likely to drop 5,088 in 2024. . At this time, Poseida Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 4.84 in 2024, whereas Price To Sales Ratio is likely to drop 4.45 in 2024. Poseida Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of July 2020 | 200 Day MA 2.9811 | 50 Day MA 2.9044 | Beta 0.536 |
Poseida |
Sharpe Ratio = 0.1269
| Best Portfolio | Best Equity | |||
| Good Returns | PSTX | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 28.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.66 actual daily | 73 73% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Poseida Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Poseida Therapeutics by adding it to a well-diversified portfolio.
Price Book 10.4829 | Enterprise Value Ebitda (1.24) | Price Sales 6.0279 | Shares Float 64.7 M | Wall Street Target Price 9.5 |
Related Headline
Passage Bio Headline on 23rd of May 2024
Acquisition by Kapadia Sandip of 47693 shares of Passage Bio... by Kapadia Sandip
Filed transaction by Passage Bio Director. Grant, award or other acquisition pursuant to Rule 16b-3
Poseida Therapeutics Valuation on May 23, 2024
It is possible to determine the worth of Poseida Therapeutics on a given historical date. On May 23, 2024 Poseida was worth 3.06 at the beginning of the trading date compared to the closed value of 2.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Poseida Therapeutics stock. Still, in general, we apply an absolute valuation method to find Poseida Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Poseida Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Poseida Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.93 | 3.11 | 2.89 | 3.06 | 485,894 | |
05/23/2024 | 3.06 | 3.07 | 2.89 | 2.95 | 415,887 |
| 2.97 | 3.00 | 2.92 | 2.97 | 136,841 |
| Backtest Poseida Therapeutics | | | Poseida Therapeutics History | | | Poseida Therapeutics Valuation | Previous | Next |
Poseida Therapeutics Trading Date Momentum on May 23, 2024
| On May 24 2024 Poseida Therapeutics was traded for 2.97 at the closing time. The top price for the day was 3.00 and the lowest listed price was 2.92 . The trading volume for the day was 136.8 K. The trading history from May 24, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 0.68% . The trading delta at closing time against the current closing price is 1.69% . |
Poseida Therapeutics Fundamentals Correlations and Trends
By evaluating Poseida Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Poseida Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Poseida financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Poseida Therapeutics Stock history
Poseida Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Poseida is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Poseida Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Poseida Therapeutics stock prices may prove useful in developing a viable investing in Poseida Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 90.2 M | 59 M | |
| Net Loss | -57.6 M | -60.5 M |
Poseida Therapeutics Quarterly Net Working Capital |
|
Poseida Therapeutics Stock Technical Analysis
Poseida Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Poseida Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Poseida Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Poseida Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Poseida Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Poseida Therapeutics shares will generate the highest return on investment. By undertsting and applying Poseida Therapeutics stock market strength indicators, traders can identify Poseida Therapeutics entry and exit signals to maximize returns
Poseida Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Poseida Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Poseida Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Poseida to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1062 | |||
| Jensen Alpha | 3.25 | |||
| Total Risk Alpha | (0.71) | |||
| Sortino Ratio | 0.7928 | |||
| Treynor Ratio | 1.28 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Poseida Stock Analysis
When running Poseida Therapeutics' price analysis, check to measure Poseida Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poseida Therapeutics is operating at the current time. Most of Poseida Therapeutics' value examination focuses on studying past and present price action to predict the probability of Poseida Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poseida Therapeutics' price. Additionally, you may evaluate how the addition of Poseida Therapeutics to your portfolios can decrease your overall portfolio volatility.